Latest filing published 11 Jan 2023 for Edesa Biotech, Inc., €31k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +43.1%Entry US$24.22 · Close at T+365 US$34.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter van der Velden: trading record in brief
All filings by Peter van der Velden on record concern Edesa Biotech, Inc. Over a trading history stretching from 7 June 2019 to 10 January 2023, the count stands at 14 filings.
On the open market, the record shows 2 purchases worth €403k and 4 sales worth €737k. Sales outweigh purchases by €333k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants. Since January 2023: no purchases and 4 sales on the market.
On 11 January 2023 came the latest disclosure, an open-market sale for €31k in Edesa Biotech, Inc. The clock since the last published purchase (10 January 2020) now reads 2,495 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter van der Velden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,284 shares@ US$2.66212.2% of flowCommon shareSEC:0001213900-23-002248:1
- 139,450 shares@ US$2.634624.8% of flowCommon shareSEC:0001213900-23-002248:2
- 12,895 shares@ US$2.63462.3% of flowCommon shareSEC:0001213900-23-002248:3
- 132,845 shares@ US$2.6621100.0% of flowCommon shareSEC:0001213900-23-002248:0
- 64,362 shares@ US$4.0016.0% of flowCommon SharesSEC:0001654954-20-011786:0
- 5,952 shares@ US$4.001.5% of flowCommon SharesSEC:0001654954-20-011786:1
- 128,722 shares@ US$3.2037.8% of flowCommon SharesSEC:0001654954-20-000270:0Canonical exit: 7 Apr 2020 (T+90)
- 11,903 shares@ US$3.203.5% of flowCommon SharesSEC:0001654954-20-000270:1Canonical exit: 7 Apr 2020 (T+90)
- 93,006 shares0Common SharesSEC:0001104659-19-042699:0
- 8,600 shares0Common SharesSEC:0001104659-19-042699:1
- 1,611,338 shares0Common SharesSEC:0001144204-19-030609:0
- 148,999 shares0Common SharesSEC:0001144204-19-030609:1
12 of 12 declarations
